MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2016 International Congress

    Quantitative assessment of DBS-induced gait disorder in patients with essential tremor

    D. Kroneberg, T. Schmitz-Hübsch, A. Gropp, G.H. Schneider, A.A. Kühn (Berlin, Germany)

    Objective: To investigate changes in gait coordination quantitatively in patients with essential tremor (ET) under chronic bilateral high-frequency stimulation of the nucleus ventralis intermedius (VIM).…
  • 2016 International Congress

    Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

    B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

    Objective: To investigate whether beta band activity (13-30Hz) and high-frequency oscillations (150-400Hz) arise from the same spatial location within the subthalamic nucleus (STN) of Parkinson's…
  • 2016 International Congress

    Combined pallidal and thalamic stimulation for multifocal primary dystonia with prominent writers’ cramp

    A. Wloch, M. Abdallat, G. Lütjens, C. Schrader, J.K. Krauss (Hannover, Germany)

    Objective: When a patient presents with both writer's cramp and other dystonic symptoms, it is unclear which target should be chosen. Multifocal DBS is a…
  • 2016 International Congress

    A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study

    D. van Poppelen, R.M.A. de Bie, J.M. Dijk (Amsterdam, Netherlands)

    Objective: To compare costs and effectiveness of the therapies DBS and CLI in advanced PD. Background: The therapies deep brain stimulation (DBS) and continuous intrajejunale…
  • 2016 International Congress

    Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

    A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate distance between the physiologically defined subthalamic nucleus (STN) target and final lead placement, and its influence on the clinical outcome at 6…
  • 2016 International Congress

    Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience

    M. Koivu, A. Huotarinen, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

    Objective: To evaluate the efficacy and adverse effects of subthalamic deep brain stimulation (STN-DBS) in patients with advanced Parkinson's disease (PD) and the possible correlation…
  • 2016 International Congress

    Identification of unique metabolite signatures in post-mortem DBS human tissue using LC-HRMS

    V. Vedam-Mai, S. Sternberg, M. Williams, T. Garrett, M.S. Okun (Gainesville, FL, USA)

    Objective: Metabolomics is applied to the study of metabolic as well as neurodegenerative diseases. We propose to utilize this technique to detect metabolic changes from…
  • 2016 International Congress

    A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease

    G. Arnulfo, N.G. Pozzi, C. Palmisano, A. Canessa, J. Brumberg, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Würzburg, Germany)

    Objective: To investigate the activity of the subthalamic nucleus (STN), and its relation to nigro-striatal dopaminergic denervation, in control of balance in Parkinson's disease (PD).…
  • 2016 International Congress

    Comparison of clinically derived and model based programming parameters of subthalamic nucleus stimulation in Parkinson’s disease

    R. Reese, M.M. Reich, R. Nilunsing, W. Pollet, J. Volkmann (Würzburg, Germany)

    Objective: To test whether DBS parameters in chronically stimulated Parkinson´s disease (PD) patients chosen by clinical criteria are congruent with DBS parameters as derived from…
  • 2016 International Congress

    Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results

    J.D. Hilliard, T. Morishita, M.S. Okun, K.D. Foote (Gainesville, FL, USA)

    Objective: Our findings have the potential to transform the clinical practice of surgeons who rely solely on indirect targeting, by raising awareness of the anatomic…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 187
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley